lamivudine has been researched along with Bullous Dermatoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aste, N; Atzori, L; Ferreli, C; Pau, M; Pilloni, L; Pinna, AL | 1 |
| Aquilina, C; Roueire, A; Viraben, R | 1 |
2 other study(ies) available for lamivudine and Bullous Dermatoses
| Article | Year |
|---|---|
Bullous skin eruption in an HIV patient during antiretroviral drugs therapy.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Eruptions; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Nelfinavir; Skin Diseases, Vesiculobullous | 2008 |
Acute generalized exanthematous pustulosis: a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor.
Topics: Acute Disease; Adult; Anti-HIV Agents; Diagnosis, Differential; Drug Eruptions; Exanthema; HIV Infections; Humans; Lamivudine; Male; Protease Inhibitors; Skin Diseases, Vesiculobullous; Zidovudine | 1998 |